Jounce Therapeutics PE Ratio 2015-2019 | JNCE

Current and historical p/e ratio for Jounce Therapeutics (JNCE) from 2015 to 2019. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Jounce Therapeutics PE ratio as of November 11, 2019 is 1.80.
Jounce Therapeutics PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2019-11-11 4.70 0.00
2019-09-30 3.33 $-0.65 0.00
2019-06-30 4.95 $-0.88 0.00
2019-03-31 6.20 $-0.81 0.00
2018-12-31 3.37 $-0.83 0.00
2018-09-30 6.50 $-1.06 0.00
2018-06-30 7.66 $-0.96 0.00
2018-03-31 22.35 $-0.93 0.00
2017-12-31 12.75 $-0.55 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.135B $0.065B
Jounce Therapeutics, Inc. is a clinical-stage immunotherapy company. It engaged in developing therapies which enable the immune system to attack tumors. The Company's lead product candidate, JTX-2011, is a clinical-stage monoclonal antibody that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of certain T cells found in a range of solid tumors. It also developing JTX-4014 for use in future combinations with JTX-2011, as well as for use in combination with other future product candidates. Jounce Therapeutics, Inc. is based in Cambridge, United States.
Stock Name Country Market Cap PE Ratio
Takeda Pharmaceutical (TAK) Japan $62.561B 9.89
Zoetis (ZTS) United States $56.137B 33.58
Astellas Pharma (ALPMY) Japan $33.066B 15.76
Eisai (ESALY) Japan $19.882B 38.34
Merck (MKGAF) Germany $15.419B 21.04
Grifols, S.A (GRFS) Spain $14.796B 18.88
UCB SA (UCBJF) Belgium $14.669B 0.00
Neurocrine Biosciences (NBIX) United States $10.201B 481.61
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
IPSEN SA ADR (IPSEY) France $8.999B 0.00
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.638B 0.00
Ionis Pharmaceuticals (IONS) United States $8.026B 16.26
Sage Therapeutics (SAGE) United States $7.563B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.362B 9.40
Catalent (CTLT) United States $7.245B 29.48
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.214B 0.00
Orion OYJ (ORINY) Finland $5.849B 30.12
STADA ARZNEIMI (STDAF) Germany $5.375B 0.00
Hypermarcas (HYPMY) Brazil $5.320B 19.13
United Therapeutics (UTHR) United States $4.020B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.992B 91.52
FibroGen (FGEN) United States $3.617B 90.48
Nektar Therapeutics (NKTR) United States $3.513B 0.00
Evotec AG (EVTCY) Germany $3.183B 43.58
Taro Pharmaceutical Industries (TARO) Israel $2.962B 10.82
PTC Therapeutics (PTCT) United States $2.538B 0.00
Tilray (TLRY) Canada $2.287B 0.00
Portola Pharmaceuticals (PTLA) United States $2.214B 0.00
Zogenix (ZGNX) United States $1.920B 0.00
Xencor (XNCR) United States $1.887B 57.35
Pacira Pharmaceuticals (PCRX) United States $1.833B 54.35
Ironwood Pharmaceuticals (IRWD) United States $1.728B 55.10
Corcept Therapeutics (CORT) United States $1.715B 20.85
Heron Therapeutics (HRTX) United States $1.714B 0.00
USANA Health Sciences (USNA) United States $1.641B 17.51
Enanta Pharmaceuticals (ENTA) United States $1.250B 20.62
CLINIGEN GP (CLIGF) United Kingdom $1.244B 0.00
Radius Health (RDUS) United States $1.147B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.997B 0.00
Endo (ENDP) Ireland $0.982B 1.80
Spectrum Pharmaceuticals (SPPI) United States $0.973B 0.00
ArQule (ARQL) United States $0.925B 0.00
Karyopharm Therapeutics (KPTI) United States $0.924B 0.00
Aerie Pharmaceuticals (AERI) United States $0.891B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.817B 5.57
Dova Pharmaceuticals (DOVA) United States $0.806B 0.00
TherapeuticsMD (TXMD) United States $0.773B 0.00
Organogenesis Holdings (ORGO) United States $0.682B 0.00
Collegium Pharmaceutical (COLL) United States $0.669B 0.00
Flexion Therapeutics (FLXN) United States $0.627B 0.00
Translate Bio (TBIO) United States $0.565B 0.00
ChemoCentryx (CCXI) United States $0.563B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.522B 0.00
ImmunoGen (IMGN) United States $0.501B 0.00
Concordia (CXRXF) Canada $0.494B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.485B 0.00
Akebia Therapeutics (AKBA) United States $0.483B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.465B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.457B 0.00
Siga Technologies (SIGA) United States $0.450B 10.29
Dermira (DERM) United States $0.449B 0.00
OptiNose (OPTN) United States $0.414B 0.00
Recro Pharma (REPH) United States $0.391B 0.00
Indivior (INVVY) United States $0.387B 1.40
Rigel Pharmaceuticals (RIGL) United States $0.377B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.371B 16.03
Ardelyx (ARDX) United States $0.366B 0.00
DURECT (DRRX) United States $0.365B 0.00
Innate Pharma SA (IPHYF) France $0.361B 0.00
Lannett Co Inc (LCI) United States $0.361B 4.19
Molecular Templates (MTEM) United States $0.338B 0.00
Harpoon Therapeutics (HARP) United States $0.320B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.297B 0.00
GlycoMimetics (GLYC) United States $0.271B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.265B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.224B 0.00
Xeris Pharmaceuticals (XERS) United States $0.216B 0.00
KalVista Pharmaceuticals (KALV) United States $0.198B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.186B 0.00
Calithera Biosciences (CALA) United States $0.182B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.182B 0.00
Nature's Sunshine Products (NATR) United States $0.180B 31.07
MARKER THERAPEUTICS, INC (MRKR) United States $0.177B 0.00
CV Sciences (CVSI) United States $0.170B 0.00
Taiwan Liposome (TLC) Taiwan $0.166B 0.00
Concert Pharmaceuticals (CNCE) United States $0.160B 0.00
Ocular Therapeutix (OCUL) United States $0.157B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.154B 0.00
Redhill Biopharma (RDHL) Israel $0.150B 0.00
CannTrust Holdings (CTST) Canada $0.147B 0.00
Aquestive Therapeutics (AQST) United States $0.135B 0.00
MEI Pharma (MEIP) United States $0.135B 0.00
IMV INC (IMV) Canada $0.131B 0.00
Cardiome Pharma (CORV) Canada $0.117B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.094B 0.00
Majesco Entertainment (PTE) United States $0.089B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.088B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.087B 33.35
Neos Therapeutics (NEOS) United States $0.085B 0.00
MediWound (MDWD) Israel $0.082B 0.00
Aclaris Therapeutics (ACRS) United States $0.081B 0.00
Generex Biotechnology (GNBT) United States $0.077B 0.00
Otonomy (OTIC) United States $0.076B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.073B 0.00
Lipocine (LPCN) United States $0.068B 0.00
SCYNEXIS (SCYX) United States $0.065B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.064B 0.00
Natural Alternatives (NAII) United States $0.064B 9.67
Adamis Pharmaceuticals (ADMP) United States $0.062B 0.00
Champions Oncology (CSBR) United States $0.061B 0.00
Genocea Biosciences (GNCA) United States $0.060B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.059B 0.00
IntelGenx Technologies (IGXT) Canada $0.058B 0.00
Novan (NOVN) United States $0.057B 0.00
Infinity Pharmaceuticals (INFI) United States $0.056B 0.00
Medicure (MCUJF) Canada $0.056B 0.00
Pharmaxis (PXSLY) Australia $0.055B 0.00
RENEURON GP (RNUGF) United Kingdom $0.054B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.054B 0.00
Nivalis Therapeutics (ALPN) United States $0.053B 0.00
ElectroCore (ECOR) United States $0.048B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.048B 0.00
Capnia (SLNO) United States $0.045B 0.00
CTI BioPharma (CTIC) United States $0.044B 0.00
Forward Pharma (FWP) Denmark $0.042B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.040B 0.00
Mannatechorporated (MTEX) United States $0.035B 0.00
Mast Therapeutics (SVRA) United States $0.035B 0.00
Iterum Therapeutics (ITRM) Ireland $0.035B 0.00
Jaguar Animal Health (JAGX) United States $0.034B 0.00
Opexa Therapeutics (ACER) United States $0.033B 0.00
Bio-Path Holdings (BPTH) United States $0.032B 0.00
Melinta Therapeutics (MLNT) United States $0.030B 0.00
Biomerica (BMRA) United States $0.030B 0.00
China SXT Pharmaceuticals (SXTC) China $0.029B 0.00
PharmAthene (ALT) United States $0.028B 0.00
ProPhase Labs (PRPH) United States $0.021B 0.00
Heat Biologics (HTBX) United States $0.017B 0.00
Flex Pharma (SLRX) United States $0.017B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.015B 0.00
Regulus Therapeutics (RGLS) United States $0.014B 0.00
Cyanotech (CYAN) United States $0.014B 0.00
Shineco (TYHT) China $0.014B 17.17
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
HANCOCK JAFFE (HJLI) United States $0.010B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.009B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.008B 0.00
Achieve Life Sciences (ACHV) United States $0.008B 0.00
Vical (BBI) United States $0.007B 0.00
RXi Pharmaceuticals (PHIO) United States $0.007B 0.00
VAXART, INC (VXRT) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Onconova Therapeutics (ONTX) United States $0.003B 0.00
Midatech Pharma (MTP) United Kingdom $0.003B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.001B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00